Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 201,000 | 180,000 | 99,000 | 55,000 | 84,000 |
| Marketable Securities | N/A | N/A | N/A | 28,000 | N/A |
| Receivables | 379,000 | 370,000 | 391,000 | 377,000 | 370,000 |
| Inventories | 292,000 | 303,000 | 324,000 | 319,000 | 361,000 |
| Income taxes - deferred | N/A | 174,000 | N/A | N/A | N/A |
| Other current assets | 251,000 | 0 | 213,000 | 219,000 | 246,000 |
| TOTAL | $1,123,000 | $1,106,000 | $1,027,000 | $998,000 | $1,061,000 |
| Non-Current Assets | |||||
| PPE Net | 608,000 | 592,000 | 608,000 | 584,000 | 565,000 |
| Investments And Advances | 0 | 154,000 | 0 | 0 | 0 |
| Intangibles | 2,031,000 | 2,064,000 | 1,960,000 | 1,883,000 | 1,689,000 |
| Other Non-Current Assets | 253,000 | 58,000 | 169,000 | 125,000 | 210,000 |
| TOTAL | $2,892,000 | $2,868,000 | $2,737,000 | $2,592,000 | $2,464,000 |
| Total Assets | $4,015,000 | $3,974,000 | $3,764,000 | $3,590,000 | $3,525,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 406,000 | 54,000 | 478,000 | 469,000 | 420,000 |
| Accrued Expenses | N/A | 421,000 | N/A | N/A | N/A |
| Other current liabilities | 149,000 | 10,000 | 115,000 | 104,000 | 139,000 |
| TOTAL | $889,000 | $831,000 | $941,000 | $1,129,000 | $899,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 909,000 | 973,000 | 859,000 | 568,000 | 568,000 |
| Other Non-Current Liabilities | 115,000 | 112,000 | 100,000 | 96,000 | 97,000 |
| TOTAL | $1,024,000 | $1,128,000 | $959,000 | $664,000 | $665,000 |
| Total Liabilities | $1,913,000 | $1,959,000 | $1,900,000 | $1,793,000 | $1,564,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 811,952 | 805,589 | 806,682 | 804,811 | 802,845 |
| Common Shares | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 |
| Retained earnings | 1,113,000 | 1,031,000 | 969,000 | 920,000 | 1,100,000 |
| Other shareholders' equity | -80,000 | -72,000 | -115,000 | -113,000 | -108,000 |
| TOTAL | $2,102,000 | $2,015,000 | $1,864,000 | $1,797,000 | $1,961,000 |
| Total Liabilities And Equity | $4,015,000 | $3,974,000 | $3,764,000 | $3,590,000 | $3,525,000 |